Threshold Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A)
September 08 2008 - 5:13PM
Edgar (US Regulatory)
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
SCHEDULE
13G/A
(Rule
13d-102)
INFORMATION
TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND
(d)
AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13D-2
(
AMENDMENT
NO. 4 )*
Threshold Pharmaceuticals,
Inc.
(Name of
Issuer)
Common Stock, $0.001 par value
per share
(Title of
Class of Securities)
(CUSIP
Number)
August
29, 2008
(Date of
Event Which Requires Filing of This Statement)
Check the
appropriate box to designate the rule pursuant to which this Schedule is
filed:
o
Rule
13d-1(b)
ý
Rule
13d-1(c)
o
Rule
13d-1(d)
*The
remainder of this cover page shall be filled out for a reporting person’s
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The
information required in the remainder of this cover page shall not be deemed to
be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934
(“Act”) or otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see the
Notes).
|
|
Page 2 of 8
Pages
|
1
|
NAMES
OF REPORTING PERSONS
I.R.S.
IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
TANG
CAPITAL PARTNERS, LP
|
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
(a)
o
(b)
ý
|
3
|
SEC
USE ONLY
|
4
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
DELAWARE
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE
VOTING POWER
0
|
6
|
SHARED
VOTING POWER
|
7
|
SOLE
DISPOSITIVE POWER
0
|
8
|
SHARED
DISPOSITIVE POWER
|
9
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
10
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES
¨
|
11
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.20%
|
12
|
TYPE
OF REPORTING PERSON
PN
|
CUSIP
No. 885807206
|
|
Page 3 of 8
Pages
|
1
|
NAMES
OF REPORTING PERSONS
I.R.S.
IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
TANG
CAPITAL MANAGEMENT, LLC
|
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
(a)
o
(b)
ý
|
3
|
SEC
USE ONLY
|
4
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
DELAWARE
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE
VOTING POWER
0
|
6
|
SHARED
VOTING POWER
|
7
|
SOLE
DISPOSITIVE POWER
0
|
8
|
SHARED
DISPOSITIVE POWER
|
9
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
10
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES
¨
|
11
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.20%
|
12
|
TYPE
OF REPORTING PERSON
OO
|
CUSIP
No. 885807206
|
|
Page 4 of 8
Pages
|
1
|
NAMES
OF REPORTING PERSONS
I.R.S.
IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
|
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
(a)
o
(b)
ý
|
3
|
SEC
USE ONLY
|
4
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
UNITED
STATES
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE
VOTING POWER
23,231
|
6
|
SHARED
VOTING POWER
|
7
|
SOLE
DISPOSITIVE POWER
23,231
|
8
|
SHARED
DISPOSITIVE POWER
|
9
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
10
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES
¨
|
11
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.99%
|
12
|
TYPE
OF REPORTING PERSON
IN
|
Item 1(a).
|
Name
of Issuer:
|
|
|
|
Threshold
Pharmaceuticals, Inc., a Delaware corporation (the
“Issuer”)
|
|
|
Item
1(b).
|
Address
of Issuer’s Principal Executive Offices:
|
|
|
|
1300
Seaport Boulevard, Redwood City, California 94063
|
|
|
Item
2(a).
|
Name
of Person Filing:
|
|
|
|
This
Statement on Schedule 13G (this “Statement”) is filed by Tang Capital
Partners, LP (“Tang Capital Partners”); Tang Capital Management, LLC, the
general partner of Tang Capital Partners (“Tang Capital Management”); and
Kevin C. Tang, the manager of Tang Capital Management.
|
|
|
Item
2(b).
|
Address
of Principal Business Office or, if none, Residence:
|
|
|
|
4401
Eastgate Mall, San Diego, CA 92121
|
|
|
Item
2(c).
|
Citizenship:
|
|
|
|
Tang
Capital Partners is a Delaware limited partnership. Tang Capital
Management is a Delaware limited liability company. Mr. Tang is a United
States citizen.
|
|
|
Item
2(d).
|
Title
of Class of Securities:
|
|
|
|
Common
Stock, $0.001 par value per share (the “Common
Stock”)
|
|
|
Item 2(e).
|
CUSIP
Number:
885807206
|
Item 3.
|
Not
applicable.
|
|
|
Item 4.
|
Ownership.
|
|
|
|
|
|
(a)
|
Amount
Beneficially Owned:
|
|
|
|
|
|
|
Tang Capital
Partners.
Tang Capital Partners is the record and
beneficial owner of 1,399,877 shares of Common Stock and shares
voting and dispositive power over such securities with Tang Capital
Management and Kevin C. Tang.
|
|
|
|
|
|
|
Tang
Capital Management.
Tang
Capital Management, as the general partner of Tang Capital Partners, may
be deemed to beneficially own the 1,399,877 shares held of record
by Tang Capital Partners and shares voting and dispositive power over such
shares with Tang Capital Partners and Kevin C. Tang.
|
|
|
|
|
|
|
Kevin
C. Tang.
Kevin
C. Tang may be deemed to beneficially own 1,520,603 shares of the
Issuer’s Common Stock, comprising:
|
|
|
|
|
|
|
●
|
1,399,877
shares owned of record by Tang Capital Partners, for which Tang Capital
Management, of which Mr. Tang is manager, serves as general
partner. Mr. Tang shares voting and dispositive power over such
shares with Tang Capital Management and Tang Capital
Partners.
|
|
|
|
|
|
|
●
|
4,716
shares owned of record by Mr.
Tang.
|
|
|
●
|
116,010 shares
over which Mr. Tang has voting and/or dispositive
power.
|
|
|
|
|
|
|
Mr. Tang disclaims
beneficial ownership of all shares reported herein except to the extent of
his pecuniary interest therein.
In
addition to the foregoing shares, Tang Capital Partners holds a warrant to
purchase 294,117 shares of the Issuer's Common Stock at an exercise price
of $2.34 per share and an expiration date of August 29,
2013.
The
above warrant provides that in no event shall the warrant be exercisable
to the extent that the issuance of Common Stock upon exercise thereof,
after taking into account the Common Stock then owned by Tang Capital
Partners and its affiliates, would result in the beneficial ownership by
Tang Capital Partners and its affiliates of more than 9.99% of the
outstanding Common Stock (the "Issuance Limitation"). Tang Capital
Partners has the express right to waive the Issuance Limitation upon
sixty-one (61) days written notice to the Issuer. The Issuance Limitation
presently remains in effect with respect to such warrant and no shares are
currently issuable upon exercise of such warrant. Neither the filing of
this Schedule 13G nor any of its contents shall be deemed to constitute an
admission by Tang Capital Partners or any other person that it is the
beneficial owner of any of the Common Stock underlying such warrant for
purposes of Section 13(d) of the Securities Exchange Act of 1934, as
amended, or for any other purpose, and such beneficial ownership is
expressly disclaimed.
|
|
(b)
|
Percent
of Class:
|
|
|
|
|
|
Tang
Capital Partners
|
9.20%
|
|
|
Tang
Capital Management
|
9.20%
|
|
|
Kevin
C. Tang
|
9.99%
|
|
|
|
|
(c)
|
Number
of shares as to which such person has:
|
|
|
|
|
|
(i)
|
sole
power to vote or to direct the vote:
|
|
|
|
|
|
|
|
|
Tang
Capital Partners
|
0
shares
|
|
|
|
Tang
Capital Management
|
0
shares
|
|
|
|
Kevin
C. Tang
|
23,231 shares
|
|
|
|
|
|
|
|
(ii)
|
shared
power to vote or to direct the vote:
|
|
|
|
|
|
|
|
|
Tang
Capital Partners
|
1,399,877
shares
|
|
|
|
Tang
Capital Management
|
1,399,877
shares
|
|
|
|
Kevin
C. Tang
|
1,479,415 shares
|
|
|
|
|
|
|
|
(iii)
|
sole
power to dispose or to direct the disposition of:
|
|
|
|
|
|
|
|
|
Tang
Capital Partners
|
0
shares
|
|
|
|
Tang
Capital Management
|
0
shares
|
|
|
|
Kevin
C. Tang
|
23,231
shares
|
|
|
|
|
|
|
|
(iv)
|
shared
power to dispose or to direct the disposition of:
|
|
|
|
|
|
|
|
|
Tang
Capital Partners
|
1,399,877
shares
|
|
|
|
Tang
Capital Management
|
1,399,877 shares
|
|
|
|
Kevin
C. Tang
|
1,497,372 shares
|
Item 5.
|
Ownership of Five Percent or
Less of a Class.
|
|
|
|
If
this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more
than five percent of the class of securities, check the
following:
¨
|
|
|
Item 6.
|
Ownership of More than Five
Percent on Behalf of Another Person.
|
|
|
|
Not
applicable.
|
|
|
Item 7.
|
Identification and
Classification of the Subsidiary Which Acquired the Security Being
Reported on by the Parent Holding Company.
|
|
|
|
Not
applicable.
|
|
|
Item 8.
|
Identification and
Classification of Members of the Group.
|
|
|
|
Not
applicable.
|
|
|
Item 9.
|
Notice of Dissolution of
Group.
|
|
|
|
Not
applicable.
|
Item 10.
|
Certification.
|
|
|
|
By
signing below I certify that, to the best of my knowledge and belief, the
securities referred to above were not acquired and are not held for the
purpose of or with the effect of changing or influencing the control of
the issuer of the securities and were not acquired and are not held in
connection with or as a participant in any transaction having that purpose
or effect.
|
SIGNATURE
After
reasonable inquiry and to the best of my knowledge and belief, I certify that
the information set forth in this statement is true, complete and
correct.
Date:
|
September 8,
2008
|
|
|
|
|
TANG
CAPITAL PARTNERS, LP
|
|
|
By: Tang
Capital Management, LLC, its General Partner
|
|
|
By:
|
/s/
Kevin C. Tang
|
|
Kevin
C. Tang, Manager
|
|
|
|
TANG
CAPITAL MANAGEMENT, LLC
|
|
|
By:
|
/s/
Kevin C. Tang
|
|
Kevin
C. Tang, Manager
|
|
|
|
|
/s/
Kevin C. Tang
|
Kevin
C. Tang
|
Page 8 of 8 pages
Threshold Pharmaceuticals (MM) (NASDAQ:THLDD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Threshold Pharmaceuticals (MM) (NASDAQ:THLDD)
Historical Stock Chart
From Jul 2023 to Jul 2024